TLR9 and neoplasm: In fact, B cell lymphoma may represent an unusual case, as it was unexpectedly found that tumour rejection did not require host expression of TLR9, and was associated with increased expression of the co-stimulatory molecules CD80 and CD86 on the lymphoma cells; the lymphoma cells themselves may therefore be acting as APCs [82].